Gene · 359
Papers3,878
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,878
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptomic Analysis Exploring the Role of Aquaporins in the Pathogenesis of Thoracic Aortic Aneurysm. | Ann Thorac Surg | 2026 | 40886758 | PubTator, text mining | PubMed |
| Type 1 Bartter syndrome presenting as primary diabetes insipidus: a rare Case Report with 8-year follow-up. | Front Genet | 2025 | 41393191 | PubTator, text mining | PubMed |
| Evolution of proteolysis-targeting chimeras (PROTAC) technology to overcome challenges of antimicrobial resistance. | NPJ Antimicrob Resist | 2025 | 41345312 | PubTator, text mining | PubMed |
| Avian coronavirus IBV-induced activation of the NLRP3-Caspase-1-IL-1β axis in renal collecting ducts contributes to nephropathogenesis. | J Virol | 2025 | 41334910 | PubTator, text mining | PubMed |
| Editorial: The fertilization success from the Oocyte's perspective, volume II. | Front Cell Dev Biol | 2025 | 41293418 | PubTator, text mining | PubMed |
| Clinical outcomes among children with primary nephrogenic diabetes insipidus. | Clin Kidney J | 2025 | 41195290 | PubTator, text mining | PubMed |
| The utility of urine biomarkers in diuretic resistance prediction in heart failure hospitalization. | ESC Heart Fail | 2025 | 41163405 | PubTator, text mining | PubMed |
| Functional characterization and cAMP-mediated rescue of a novel truncating AVPR2 mutation causing nephrogenic diabetes insipidus. | Am J Physiol Endocrinol Metab | 2025 | 41071673 | PubTator, text mining | PubMed |
| Regulation of aquaporin-2 using traditional Chinese medicine in water balance disorders: a literature review. | Front Cardiovasc Med | 2025 | 41063833 | PubTator, text mining | PubMed |
| Empagliflozin and fluid balance: results from the SiRENA project. | Clin Kidney J | 2025 | 40994705 | PubTator, text mining | PubMed |
| Novel AVPR2 mutations in congenital nephrogenic diabetes insipidus: clinical characteristics and genetic analysis. | Front Pediatr | 2025 | 40989819 | PubTator, text mining | PubMed |
| Bio fluid exosomes: promises, challenges, and future directions in translational medicine. | J Transl Med | 2025 | 40988065 | PubTator, text mining | PubMed |
| Aquaporin 2 is differentially expressed in granulosa cells of various stages of human follicles and is regulated by luteinizing hormone. | Front Cell Dev Biol | 2025 | 40900732 | PubTator, text mining | PubMed |
| Identification and verification of exosome-related gene signature to predict the cancer status and prognosis of prostate cancer. | Discov Oncol | 2025 | 40900420 | PubTator, text mining | PubMed |
| Refining the Composition and Significance of Human Renal Intratubular Casts Using Spatial Protein Imaging. | medRxiv | 2025 | 40894126 | PubTator, text mining | PubMed |
| FGF9 treatment reduces off-target chondrocytes from iPSC-derived kidney organoids. | NPJ Regen Med | 2025 | 40885721 | PubTator, text mining | PubMed |
| Controlling nephron precursor differentiation to generate proximal-biased kidney organoids with emerging maturity. | Nat Commun | 2025 | 40885711 | PubTator, text mining | PubMed |
| A Novel Pathogenic Variant of the AVPR2 Gene Leading to Arginine Vasopressin Resistance Since the Neonatal Period. | Genes (Basel) | 2025 | 40870037 | PubTator, text mining | PubMed |
| Focal adhesion kinase inhibition induces membrane accumulation of aquaporin-2 in renal epithelial cells by actin depolymerization and endocytosis inhibition. | Am J Physiol Renal Physiol | 2025 | 40857140 | PubTator, text mining | PubMed |
| Bardet-Biedl syndrome: a rare cause of end-stage kidney disease. Case report. | Ann Med Surg (Lond) | 2025 | 40852023 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/359/papers?page=3